Billing team should verify whether the practice's current BPH billing procedures and prior authorization workflows align with Aetna's covered procedures (CPT codes 52282, 52441, 52442, 52443, 52450, 52597, 52601, 52648, 52649, 53850, 53854, 53855, 53865, 53866, 37243, and 52281) and confirm that experimental/investigational procedures (including CPT codes 0655T, 0714T, 0867T, 0950T, 37242, 37244, 55873, and 75894) are not being billed for BPH indications without proper denial handling. Confirm current applicability with Aetna, as the 2026-10-15 review date does not establish a change effective date. Ensure UroLume and iTind coding reflects the policy's coverage limitations (age, prostate size, and indication restrictions). Check benefit plan descriptions for plan-specific exclusions, particularly for tadalafil coverage.